Literature DB >> 23354658

Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT.

Lei Wang1, Yan Zhang, Chaowu Yan, Jianguo He, Changming Xiong, Shihua Zhao, Wei Fang.   

Abstract

BACKGROUND: Right ventricular (RV) function is a powerful predictor of survival in patients with pulmonary hypertension (PH), but noninvasively assessing RV function remains a challenge. The aim of this study was to prospectively compare gated (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) myocardial imaging (gated PET), cardiac magnetic resonance (CMR), and cardiac computed tomography (CCT) for the assessment of RV volume and ejection fraction in patients with PH.
METHODS: Twenty-three consecutive patients aged more than 16 years diagnosed with PH were included. All patients underwent gated PET, CMR, and CCT within 7 days. Right ventricular end-diastolic volume (RVEDV), right ventricular end-systolic volume (RVESV), and right ventricular ejection fraction (RVEF) were calculated by three imaging modalities. RV (18)F-FDG uptake was determined as RV-corrected standardized uptake value (SUV), and the ratio of RV to left ventricular (LV)-corrected SUV (Corrected SUV R/L).
RESULTS: Gated PET showed a moderate correlation (r = 0.680, P < .001) for RVEDV, good correlation for RVESV (r = 0.757, P < .001) and RVEF (r = 0.788, P < .001) with CMR, and good correlation for RVEDV (r = 0.767, P < .001), RVESV (r = 0.837, P < .001), and RVEF (r = 0.730, P < .001) with CCT. Bland-Altman analysis revealed systematic underestimation of RVEDV and RVESV and overestimation of RVEF with gated PET compared with CMR and CCT. The correlation between RVESV (r = 0.863, P < .001), RVESV (r = 0.903, P < .001), and RVEF (r = 0.853, P < .001) of CMR and those of CCT was excellent; Bland-Altman analysis showed only a slight systematic variation between CMR and CCT. There were statistically significant negative correlations between RV-corrected SUV and RVEF-CMR (r = -0.543, P < .01), Corrected SUV R/L and RVEF-CMR (r = -0.521, P < .05), RV-corrected SUV and RVEF-CCT (r = -0.429, P < .05), Corrected SUV R/L and RVEF-CCT (r = -0.580, P < .01), respectively.
CONCLUSION: Gated PET had moderate-to-high correlation with CMR and CCT in the assessments of RV volume and ejection fraction. It is an available method for simultaneous assessing of RV function and myocardial glucose metabolism in patients with PH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354658     DOI: 10.1007/s12350-013-9672-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  33 in total

1.  EFFECT OF FASTING ON GLUCOSE AND PALMITATE METABOLISM OF PERFUSED RAT HEART.

Authors:  L H OPIE; J R EVANS; J C SHIPP
Journal:  Am J Physiol       Date:  1963-12

2.  Quantification of left and right ventricular function and myocardial mass: comparison of low-radiation dose 2nd generation dual-source CT and cardiac MRI.

Authors:  Richard A P Takx; Antonio Moscariello; U Joseph Schoepf; J Michael Barraza; John W Nance; Gorka Bastarrika; Marco Das; Mathias Meyer; Joachim E Wildberger; Stefan O Schoenberg; Christian Fink; Thomas Henzler
Journal:  Eur J Radiol       Date:  2011-08-09       Impact factor: 3.528

3.  Right-sided cardiac function in healthy volunteers measured by first-pass radionuclide ventriculography and gated blood-pool SPECT: comparison with cine MRI.

Authors:  Andreas Kjaer; Anne-Mette Lebech; Birger Hesse; Claus Leth Petersen
Journal:  Clin Physiol Funct Imaging       Date:  2005-11       Impact factor: 2.273

4.  Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance.

Authors:  Subha V Raman; Mona Shah; Beth McCarthy; Anne Garcia; Amy K Ferketich
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

5.  Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging.

Authors:  Hadassa A Hofman; Paul Knaapen; Ronald Boellaard; Olga Bondarenko; Marco J W Götte; Willem G van Dockum; Cees A Visser; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

6.  Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy.

Authors:  S V Abramson; J F Burke; J J Kelly; J G Kitchen; M J Dougherty; D F Yih; F C McGeehin; J W Shuck; T P Phiambolis
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

7.  Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension.

Authors:  Mehmet Mustafa Can; Cihangir Kaymaz; Ibrahim Halil Tanboga; Hacer Ceren Tokgoz; Nesrin Canpolat; Erdem Turkyilmaz; Kenan Sonmez; Nihal Ozdemir
Journal:  Clin Nucl Med       Date:  2011-09       Impact factor: 7.794

8.  Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary disease and cor pulmonale.

Authors:  Yan Gao; Xiangying Du; Lei Liang; Lizhen Cao; Qi Yang; Kuncheng Li
Journal:  Eur J Radiol       Date:  2010-11-27       Impact factor: 3.528

9.  Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans Juergen Kaiser; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

10.  Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans-Juergen Kaiser; Patrick Reinartz; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

View more
  15 in total

1.  Sample size considerations for clinical research studies in nuclear cardiology.

Authors:  Cody Chiuzan; Erin A West; Jimmy Duong; Ken Y K Cheung; Andrew J Einstein
Journal:  J Nucl Cardiol       Date:  2015-09-24       Impact factor: 5.952

2.  Positron emission tomography: An additional prognostic tool in dilated cardiomyopathy?

Authors:  Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

3.  CT compared to MRI for functional evaluation of the right ventricle: a systematic review and meta-analysis.

Authors:  Hang Fu; Xuedong Wang; Kaiyue Diao; Shan Huang; Hui Liu; Yue Gao; Qin Zhao; Zhi-Gang Yang; Ying-Kun Guo
Journal:  Eur Radiol       Date:  2019-05-27       Impact factor: 5.315

4.  An official American Thoracic Society Statement: pulmonary hypertension phenotypes.

Authors:  Raed A Dweik; Sharon Rounds; Serpil C Erzurum; Stephen Archer; Karen Fagan; Paul M Hassoun; Nicholas S Hill; Marc Humbert; Steven M Kawut; Michael Krowka; Evangelos Michelakis; Nicholas W Morrell; Kurt Stenmark; Rubin M Tuder; John Newman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

5.  Right ventricular dyssynchrony in pulmonary hypertension: Phase analysis using FDG-PET imaging.

Authors:  Lei Wang; Weihua Zhou; Yu Liang; Yong Yang; Ernest V Garcia; Ji Chen; Wei Fang
Journal:  J Nucl Cardiol       Date:  2015-12-29       Impact factor: 5.952

Review 6.  FDG PET imaging for identifying pulmonary hypertension and right heart failure.

Authors:  Ali Ahmadi; Hiroshi Ohira; Lisa M Mielniczuk
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

7.  The characterization and prognostic significance of right ventricular glucose metabolism in non-ischemic dilated cardiomyopathy.

Authors:  Lei Wang; Xinghong Ma; Liwei Xiang; Minjie Lu; Chaowu Yan; Shihua Zhao; Wei Fang
Journal:  J Nucl Cardiol       Date:  2015-08-08       Impact factor: 5.952

8.  The role of nuclear imaging in pulmonary hypertension.

Authors:  H Ohira; R S Beanlands; R A Davies; L Mielniczuk
Journal:  J Nucl Cardiol       Date:  2014-08-27       Impact factor: 5.952

9.  The role of PET quantification in cardiovascular imaging.

Authors:  Piotr Slomka; Daniel S Berman; Erick Alexanderson; Guido Germano
Journal:  Clin Transl Imaging       Date:  2014-08-01

10.  Growing applications of FDG PET-CT imaging in non-oncologic conditions.

Authors:  Hongming Zhuang; Ion Codreanu
Journal:  J Biomed Res       Date:  2015-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.